Table 2. Summary of 8 patients who underwent additional treatments due to tumor progression.
| Case No. | Age | Sex | Residual TV, cm3 | Time to progression, mon | TV at progression, cm3 | Treatment | |
|---|---|---|---|---|---|---|---|
| 2nd | 3rd | ||||||
| 1 | 33 | F | 0.7 | 14.3 | 3.6 | GKRS | |
| 2 | 45 | F | 2.4 | 52.2 | 4.2 | GKRS | |
| 3 | 71 | M | 4.5 | 3.2 | 13.8 | Surgery | |
| 4 | 35 | F | 6.5 | 19.7 | 12.6 | Surgery | GKRS |
| 5 | 52 | M | 7.5 | 52.1 | 5.8 | GKRS | |
| 6 | 28 | F | 12.5 | 17.0 | 9.9 | GKRS | Surgery |
| 7 | 60 | F | 19.8 | 14.6 | 14.6 | Surgery | GKRS |
| 8 | 33 | M | 27.4 | 5.2 | 35.2 | Surgery | |
| Median (range) | 7.0 (0.7–27.4) | 15.8 (3.2–52.2) | |||||
TV = tumor volume, GKRS = gamma knife radiosurgery.